Bright Minds Biosciences Inc. (DRUG)
NASDAQ: DRUG · Real-Time Price · USD
88.99
-1.25 (-1.39%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Bright Minds Biosciences Employees
Bright Minds Biosciences had 26 employees as of September 30, 2025. The number of employees increased by 25 or 2,500.00% compared to the previous year.
Employees
26
Change (1Y)
25
Growth (1Y)
2,500.00%
Revenue / Employee
n/a
Profits / Employee
-$556,655
Market Cap
854.82M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 26 | 25 | 2,500.00% |
| Sep 30, 2024 | 1 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| MannKind | 592 |
| MeiraGTx Holdings | 403 |
| Phathom Pharmaceuticals | 371 |
| Xencor | 260 |
| Janux Therapeutics | 109 |
| Theravance Biopharma | 90 |
| CytomX Therapeutics | 69 |
| Alto Neuroscience | 68 |
DRUG News
- 15 days ago - DRUG Initiates Coverage On Bright Minds Biosciences -- Price Target Announced - GuruFocus
- 7 weeks ago - Bright Minds Biosciences Inc at TD Cowen Healthcare Conference Transcript - GuruFocus
- 7 weeks ago - Bright Minds Biosciences Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - Bright Minds Biosciences to Present at Upcoming Conferences - GlobeNewsWire
- 2 months ago - BTIG Maintains Buy Rating for Bright Minds Biosciences (DRUG) with $147 Target | DRUG Stock News - GuruFocus
- 3 months ago - Bright Minds Biosciences Announces Closing of US$175 Million Public Offering - GlobeNewsWire
- 3 months ago - Bright Minds Biosciences (DRUG) Prices $175M Public Offering - GuruFocus
- 3 months ago - Bright Minds Biosciences Announces Pricing of Upsized US$175 Million Public Offering of Common Stock - GlobeNewsWire